Cargando…

Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines

Detalles Bibliográficos
Autores principales:	Nacif, Marcelo, Arai, Andrew E, Lima, Joao A, Bluemke, David A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305027/ http://dx.doi.org/10.1186/1532-429X-14-S1-P46

Ejemplares similares

Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
por: Nacif, Marcelo S, et al.
Publicado: (2012)

Quantification of myocardial scar assessed by late gadolinium enhancement CMR in the multi-ethnics study of atherosclerosis: comparisons of 7 different methods
por: Rizzi, Patricia B, et al.
Publicado: (2013)

Anomalous origin of left coronary artery diagnosed by magnetic resonance imaging
por: Falcão, Ricardo Oliveira, et al.
Publicado: (2010)

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Submillimeter diffusion tensor imaging and late gadolinium enhancement cardiovascular magnetic resonance of chronic myocardial infarction
por: Pashakhanloo, Farhad, et al.
Publicado: (2017)

Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials
por: Liu, Songtao, et al.
Publicado: (2012)

Three-Dimensional Volumetric Assessment of Diastolic Function by Cardiac Magnetic Resonance Imaging: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Nacif, Marcelo S, et al.
Publicado: (2017)

Sample size calculation for clinical trials using cardiac magnetic resonance partition coefficient and extracellular volume fraction for the assessment of diffuse myocardial fibrosis
por: Liu, Songtao, et al.
Publicado: (2013)

Myocardial tissue tagging with cardiovascular magnetic resonance
por: Shehata, Monda L, et al.
Publicado: (2009)

Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations
por: Hundley, W Gregory, et al.
Publicado: (2009)

Gadolinium-enhanced magnetic resonance angiography in brain death
por: Luchtmann, M., et al.
Publicado: (2014)

Magnetic resonance imaging of endolymphatic hydrops: a comparison of methods with and without gadolinium-based contrast agent administration
por: Ohashi, Toshio, et al.
Publicado: (2023)

Gadolinium‐containing carbon nanomaterials for magnetic resonance imaging: Trends and challenges
por: Rodríguez‐Galván, Andrés, et al.
Publicado: (2020)

Neurotoxic manifestations of high-dose intrathecal gadolinium administration for CT myelogram
por: Malalur, Pannaga, et al.
Publicado: (2020)

Gadolinium-Coated Mesoporous Silica Nanoparticle for Magnetic Resonance Imaging
por: Li, Zhongtao, et al.
Publicado: (2022)

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Cardiovascular Computed Tomography and Magnetic Resonance: History and Growing Impact in Brazil and in the World
por: Nacif, Marcelo Souto, et al.
Publicado: (2014)

Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations
por: Hundley, W. Gregory, et al.
Publicado: (2022)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T(1) relaxometry in patients with prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2020)

Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging
por: Salas, Mauro, et al.
Publicado: (2021)

Myocardial Viability on Cardiac Magnetic Resonance
por: Souto, Ana Luiza Mansur, et al.
Publicado: (2017)

Textural analysis of late gadolinium enhanced magnetic resonance images can discriminate acute from chronic myocardial infarction
por: Beliveau, Pascale, et al.
Publicado: (2014)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis
por: Tzogias, Leonidas, et al.
Publicado: (2009)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis
por: Kawel, Nadine, et al.
Publicado: (2012)

The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic
por: Diak, Ida-Lina, et al.
Publicado: (2022)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
por: Quail, Michael, et al.
Publicado: (2019)

Split dose versus single bolus gadolinium administration in ecv calculation at 3 tesla cmr
por: McDiarmid, Adam K, et al.
Publicado: (2015)

Information to Improve Public Perceptions of the Food and Drug Administration (FDA’s) Tobacco Regulatory Role
por: Osman, Amira, et al.
Publicado: (2018)

Diagnostic value of gadolinium contrast administration for spinal cord magnetic resonance imaging in multiple sclerosis patients and correlative markers of lesion enhancement
por: Karimian-Jazi, Kianush, et al.
Publicado: (2021)

Cardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis
por: Yoneyama, Kihei, et al.
Publicado: (2017)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009)

Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance
por: Dellinger, Anthony, et al.
Publicado: (2013)

Mannose-coated gadolinium liposomes for improved magnetic resonance imaging in acute pancreatitis
por: Tian, Bing, et al.
Publicado: (2017)

Magnetic resonance cisternography imaging findings related to the leakage of Gadolinium into the subarachnoid space
por: Nakamichi, Rei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_auutjnforuimgdaunph33903rs